2 diseases Flashcards

1
Q

types of epidemiological paradigms for disease causation (x3)

A
  1. Programming:
    - critical periods of growth: exposure here leads to outcome

eg barker hypothesis: IU malnutrition leads to CVD as adult

  1. Adult Risk factor:
    - risk factors of LIFESTYLE AND BEHAVIOUR as adult leads to outcome

eg: exercise –> outcome

  1. Life Course:
    - programming and adult risk factor together
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

top causes of death High income and low income

A

From WHO: Global health estimates 2021

top cause of death globally is IHD

High income:
- Driver: Aging population
- conditions: IHD, covid, stroke, Alzheimer’s, lung cancer, COPD, colon ca, LRTI, Kidney, HTN

Low income:
Driver: high rates of communicable disease (8/10 communicable)
conditions: LRTI, stroke, IHD, malaria, Preterm birth, covid, diarrhoeal, TB, birth, HIV

HIV deaths decreasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Global burden of disease

A

Lancet study published in 2024 for 2021 data
- Looks at DALYs

2010 -2021

KEY TAKE AWAYS
- non communicable largest burden: make up 16/25
- decrease communicable ( caveat COVID new entry at TOP )
- CMNN remain high (communicable, maternal, neonatal, nutrition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Depression

A

Clinical: low mood >2 weeks, with functional disability. Physical and mental

Aetiology: genetic, biological, environmental

Public Health relevance:
World: Commonest mental health disorder no. 12 on GBD

UK: (fingertips)
13% prevalence

Time: increasing

Person:
- ethnic minority
- W>M
- increases with age
- unemployed

Place:
- South Yorkshire and North east

Prevention:
- secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Suicide

A

Clinical: intentionally causing own death. coroner’s verdict.

Aetiology: genetic, biological, environmental

Public Health: leading cause of death for young adults. Early intervention prevents suicide

UK: (ONS)
10 per 100,000 deaths per year

Time:
-decrease since 1982
- increase 08-10 (financial crash)

Person:
- Men >women
-highest >45
- Low SEC
- other MH

Place:
- North East HIGHEST
- London lowest

Prevention:
- 1: strengthen protective factors
- 2: detect those at risk, intervention

England suicide prevention strategy 2023-28

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dementia

A

Clinical: neurodegenerative, memory loss, confusion, speech, understanding

Aetiology: Alzheimer’s 60% (beta-amyloid, tau) + Vascular (infarcts)

PH relevance:
- aging population, cost, undiagnosed, no cure

UK:
- 12% deaths due to dementia
4.3% prevalence in England

Time:
- increasing (1.6mil by 2040)

Person:
- increase with age
- W > M

place:
- IMD high
- North West, south east, north east, East England,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Schizophrenia

A

Clinical: psychosis. Positive, negative, cognitive

Aetiology: unknown

PH relevance:
- high disease burden
- high physical health burden
- stigmatised and hard to reach group

UK:
- 1% prevalence

Time:
- ?falling (poor data)

Person:
- male, 25-40, black
- low SEC
- ?cannabis use

Place:
- Urban >rural

Prevention:
- Early intervention for first presentation psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Parkinsons

A

Clinical: progressive neurological disorder that primarily affects movement. Motor + non-motor symptoms

Aetiology: loss of dopamine producing neurons in SN + lewy body

PH relevance:
- increasing with aging population
- falls, fractures and hospital admission
- social care

UK
200 per 100,000

Time:
Time: prevalence stable (Okunoye et al 2022 cohort study), but will increase as population gets older

Person: increase with age (doubles between 50-69), Male, sporadic

place: n/a

Prevention:
no routine screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Coronary heart disease

A

Clinical: inadequate blood supply to heart. Angina, MI, cardiac arrest

Aetiology: atherosclerosis

PH relevance:
- one of the top causes of death in the UK

UK:
Time: fallen since 80s

Person:
- M, increasing age,
age, lifestyle, disease, family, other

Place:
North, Scotland, wales

Prevention:
1: exercise, diet
2: treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stroke

A

Clinical: form of CVD: ischaemic or haemorrhagic
TIA

Aetiology: CVD, HTN

PH relevance:
- leading cause of death and disability
- preventable

UK
100K strokes a year

Time:
- increasing due to age (age adjusted decreasing)

Person:
male, old, low SEC

Place: n/a

Prevention:
1: lifestyle, HTN, cholestrol
2: FAST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Breast Cancer

A

Relevance: major cancer in women

Incidence: 173 per 100,000 (females)
5 year survival :85%

Time: survival increasing

Person: female, older, deprivation, white higher ethnic lower (start family early), genetic

breast cancer screening in place (50-71 every 3 years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lung Cancer

A

Relevance: high case fatality rate + preventable

Incidence: 66 per 100 000
5 year survival: 20%

Time: improving ( reducing smoking, stage shift)

Person: men, over 50

targeted lung cancer screening started (55-74)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Colorectal cancer

A

PH Relevance:
- 4th most common cancer in the UK
- known RF
- Screening

Incidence: 56.6 pr 100 000

5 year survival: 60%

Time: survival improving,

Person: older Age, diet, smoking, gastro conditions
(increasing in younger age but 90% still >50)

Screening: 50-74: Home FIT kit (then colonoscopy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prostate cancer

A

2nd most common cause of cancer in the UK

Incidence: 88 per 100,000

5 year survival: 87% 5 year survival

Time: improving

Person: Men, old, African,

Screening: ?(prostate then MRI screening: NEJM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cervical cancer

A

Common cancer in women

Incidence:
5 per 100,000
highest in females aged 30 to 34
decreasing

5 year survival: 70%
Improving

Person: gender, younger age, lower deprivation

Prevention:
Primary:
HPV vaccine (1 HPV vaccine 12/13: coverage 83% F, 65% M)

Secondary: screening
screen (25-64) uptake 72-76&
HPV first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Asthma

A

Clincal: chronic, inflam condition, shortness of breath

PH relevance:
Commonest chronic condition in childhood

UK:
Prevalence: 12%

Time

Person:
Boys, childhood, viral,

Place:
air pollution,

Prevention:
I: air quality
2: annual review, personalised asthma plan, medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

COPD

A

Clinical: Chronic bronchitis and emphysema

Public health:
- preventable (smoking)
- high mortality and morbidity

UK
- 3 million in the UK
- Common reason for ED admission and hospital readmission

Time:
- increasing

Person:
Men = women,
older age,
lower SEC,
smoking

place:

prevention:
1: stop smoking, occupational exposure

2: vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

sickle cell

A

Clinical: red blood cell disease, sickling, obstruct blood

aetiology:
Autosomal recessive (Ch 11)

Public health prevalence:
- Health inequality
- screening

UK:
Prevalence: Afro-Caribbean: 1 in 10-40 have trait 1 in 60-200 have disease
UK Prevalence: 20 per 100,000

  • Screening:
    1. blood test for mothers and fathers who mother is a carrier
  • in high prevalence areas to all women
  1. family origin questionnaire
    - in low prevalence areas then blood test
  2. Heel prick test
    - all new-borns

1 +2 then diagnostic test (CVS and amnio)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

diabetes

A

Clinical: multisystem characterised by hyperglycaemia

aetiology:
T1DM: autoimmune
T2DM: insulin resistance and relative insulin deficiency

Public health relevance:
- Increasing mortality and morbidity
- increasing prev.

UK:
- 4 million in the UK
- large undiagnosed

Time: increase

Person:
- deprived, LMIC, more common England

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Alcohol use disorder

A

clinical: drink >14 units in a week, harmful drinking + dependence

Aetiology: addiction cycle

Public health:
- short and long term effects ( HTN, stroke, CHD, pancreatitis, liver disease)

  • prevention

UK
21% of adults

time:
- overall decrease since 2000 with decrease in binge drinking in young adults

place: all 4 nations. worse scotland

person:
mortality: 39.5 per 100,00

prevention:
SAFER

Strengthen restriction

Advance drink driving counter measures

Facilitate screen and treatment

Enforce bans on advertising
promotion, sponsorship

Raise price

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Air pollution

A

overview:
- household, particulate, ozone

causes:
- transport, industry, farming, energy consumption, heating

public health importance:
- increase CVD, resp infections and diseases, maternal, neonatal, cancers

UK:
28K deaths a year due to air pollution

time:
- increasing worldwide
- decrease UK

person:
- high risk groups

place:
- cities, location to road/ polluter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

drug misuse

A

clinical: dependence leading to harm

Public health:
- preventable
- inequality
- cross-sector

UK:
- 2% drug use disorder

time:
- opioid USA, increasing UK

place:
- deprivation, Scotland

Person:
men, young

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Smoking

A

leading cause of cancer, COPD

Why PH:
- cause of cancer
- preventable
- inequality

UK:
- 13% adults smoke
- declining
- 1 in 4 cancer deaths

cost:
- England £17 billion
- productivity
- direct (healthcare costs) and indirect

Vaping:
- increasing around 13% of youth
reasons: social, and mental health

control:
tobacco and vapes bill 2024

MPOWER
Monitor tobacco use and prevention policies

Protect people from tobacco smoke

Offer help to quit tobacco use

Warn about the dangers of tobacco

Enforce bans on tobacco advertising, promotion and sponsorship

Raise taxes on tobacco

UK Gov:
1998: smoking kills (seminal white paper)

2024: tobacco and vapes bill (smoke free generation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Oral health

A

conditions: tooth decay, periodontal disease, oral cancers

Public health:
- cost £3.6billion per year
- tooth decay most common hospital admission for 5-9 year olds

UK:
- 1/4 of <5 experience tooth decay
- deprivation

time:
- better

person:
- young, elderly, LD
- homeless, prison

place:
- North West
- deprivation

prevention:
1: fluoride brush and varnish, breastfeeding, less sugar, fluoridation of drinking water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Obesity
definition: >30 BMI public health: 1 in 8 obese WW increase risk of multiple conditions (DN, cancer, HD) UK: 26% adults cost £4bill each year to the NHS primary secondary treatment: ?ozempic
26
Road traffic injuries
TBC
27
screening
the process of identifying apparently healthy people who may have an increased chance of a disease or condition. Individuals can then be offered more information, further tests or treatment as appropriate.
28
3 approached to screening
1 population: - offered to a group of people identified form the whole population, and defined eg by sex or age eg. bowel, breast, cervical 2. targeted - offer screening to a more specific group with a higher risk of a condition eg targeted lung cancer screening to smokers 3. stratified: - happens in both above - offer testing which varies in frequency and modality based on individual risk eg. HPV +ve follow different CC screening pathway, FHx of breast cancer invited more frequently.
29
Wilson and Junger
Disease – importance, preclinical course, natural history, latent period test – valid, safe, effective, acceptable, reliable, cheap Diagnosis and treatment – evidence-based, acceptable, cost-effective, safe, facilities adequate Overall programme – evidence-based, ethical (Beauchamp and Childress, informed decision and popularity paradox), legal (4 aspects), economic (opportunity cost), social (factors affecting participation)
30
Overview of national screening programmes
1. Pregnancy - infectious disease - Foetal anomaly scan - sickle and thalassemia 2. New born - Heal prick - new born and infant physical exam - new born hearing 3. Adult - Cervical cancer: 25- 64 (25-49: 3Y, 50-64: 5Y) - Bowel cancer (50-74 M and F: FIT kit) - Breast Cancer: (50-71 F. AgeX trial to x2 one off at 47-49, 71-73) - AAA ( M year turn 65) - Diabetic eye check (>12 diabetes, every year, if x2 -ve every 2 years) others: - NHS health checks - Chlamydia (targeted F) - prostate - TB
31
Cervical screening
WHY: - common cancer in women (14) - highest in females aged 30 to 34 - pre-clinical stage: dysplasia: CIN (1-3)->cancer - strategy to eliminate by 2040 High risk HPV testing, cytology, colposcopy. Impact: - estimate save 4500 lives every year - cervical rates have halved Uptake: - 30% eligible never screened - lowest in ethnic minority and young age groups, deprived - letter language, accessible appointments, discomfort HPV vaccine - 1 dose for M and F in Y8 - 9 types of HPV
32
Bowel cancer screening
WHY: - 42K cases a year - 17K deaths - 80% >60 years - -early treatment Increases survival: duke (90%) Vs metastatic (10% 5ys) Works? - risk of dying of bowel cancer by 16% What is it: - 54- 74 every 2 years (increased to 50-74) - FIT home test (blood) then colonoscopy
33
screening bias
Lead time: know ill earlier (longer lead in) length time bias: slower developing illness healthy screene effect
34
threshold parallel and serial testing
threshold: need to set cut off ROC: AUROC parallel: both tests together (downs: USS + blood test), serial: one after another (cervical)
35
Screening Vs Diagnostic test Vs case finding
case finding: strategy for targeting resources at individuals or groups who are suspected to be at risk for a particular disease. It involves actively searching systematically for at risk people, rather than waiting for them to present with symptoms or signs of active disease similar to screening - communicable disease control - health systems
36
legal aspects of screening
1. confidentiality 2. accreditation and qual 3. right to NOT screen 4. consent
37
informed choice for screening
GMC: - purpose of screening - likelihood of +ve and -ve result - risks associated with screening - implications for particular condition (medical, social, financial) - follow up
38
Genetic screening
involve testing members of a population (or sub-population) for a defect or condition, no prior evidence of its presence OR limited to a sub-population that is at particular risk of a genetic condition. Issues: 1. ethical: - 4 principles, - autonomy - reproductive choice 2. legal - consent - confidentiality - right to not be screened 3. social - stigma - counselling - disclosure to family - insurer/ employer
39
genotype vs phenotype
The set of alleles a person has is known as their genotype. This genotype then codes a set of observable characteristics which are then expressed, known as the phenotype.
40
karotype
species-specific characteristic set of chromosomes.
41
how to make a protein
1. transcription - in nucelus. RNA polymerase - mRNA from single strand DNA 2. splicing - introns removed from mRNA 3. exporting - leaves nucleus 4. translation - ribosome - mRNA adds tRNA which carries amino acis 5.protein modification 6. translocation
42
patterns of inheritence
1. monogenic AD: huntingtins AR: sickle cell x- linked: Rett syndrome 2. polygenic - many genes - alzheimers 3. chromosomal - numerical: trisomy (downs 21) loss monosomy (turners) - structural: Charcot - MTD 4. mitochondrial: Leigh disease - threshold effect
43
penetrance
proportion of people with a given genotype express phenotype
44
genetic testing
1. individual if there is an indication - medically - fhx can work out familial relative risk: risk in family/ riskin gen population done: 1. molecular tests - FISH 2. karotyping 3. non invasive prenatal: cfDNA population screening 1. Heelprick for 9 rare conditions 2. pregnant: downs, edwards, patua, SC and thalasemmia
45
nutrition
study of the the influence on food intake on health and wellbeing. Macro and micronutrients Surveillance: - routine collection and collation of data -food supply: FAO data - ONS Living cost and food survey (2023) - infant feeding survey
46
Nutritional status
1. anthropmentry - height, weigh, BMI NHS child measurement programme 2. indices - MUST 3. biochemical 4. bioelectrical impedance 5. imaging 6. food surveys
47
Dietary nutritional values
EAR (estimated average requir): Average amount needed by a group of people (i.e. 50% of the group’s requirements are met) Reference Nutritional Intake: Amount that is enough to meet the dietary needs of about 97.5% of a group of people (i.e. the majority need less) Lower Reference NI: Amount that is enough for a small number (2.5%) of people in a group with the smallest needs (most people will need more than this) Safe intake: expert opinion
48
Intersalt study
Large cross-sectional individual and ecological 52 countries, 10k people findings: - urinary Na excretion related to higher blood pressure at ecological level - BMI and alcohol independently associated with BP at ecological level -> firs evidence that Salt linked to BP
49
types of diets
Bad - western: high energy, sat fats, low fibre, high salt - South asian: high fat good: - mediterranean - japanese
50
physical activity
def: any force exerted that results in energy expenditure above resting. why important: - CVD, obesity, T2DM, cancer, mental health, skeletal health epidemiology Time: decrease in adults and children person: - lowest in asian, black and other (highest mixed) -63% in england were physically active place: - lowest Tower hamlets, higher wandsowrth
51
environmental health
all external factors and conditions that contribute to health - traditional: physical, chemical, biological - Living and working - global: Climate Kuznet curve: n shaped curve of pollutants and wealth
52
environmental hazard and risk
hazard: factor that may harm health risk: probability of event x impact
53
Sandman risk
= Hazard (size and probability) + outrage depends on: - control fair - process - morality - familiar - dread -memorable - time and space - voluntary
54
risk management
Assessment, management, communication Assessment: 1. what are the issues: vulnerable groups, what is hazard, underlying concerns 2. hazard: what is hazard, where and why important 3. exposure assessment: how, what is it, why important Management: 1. evaluation: identify and analyse 2. control: - source, pathway, receptor - immediate, medium, long term 3. monitor 4. lessons learned updated SOP Communication - throughout - sandman's risk - culturally competent
55
Transport policies (wales 20mph)
Rational: Dr Sarah Jones, to increase active travel for children --> barrier unsafe streets + reduce crashes and serious injuries + less noise and fuel usage 2023 data: 100 fewer series injuries and 10 fewer dead (lowest since records began issues: - need 3 year of data - balance of risks - communication campaign groups: 20splenty - 75% of inner londoners live on a 20mph road -
56
surveillance
ongoing systematic collection, collation, analysis, and interpretation of data and the dissemination of the information generated to facilitate disease prevention
57
principles of surveillance
1. case definition 2. cases identifies through number of sources 3. data collection tool 3. systematic collection of case data = case definition 4. analysis 6. feedback to data providers 7. dissemination and use
58
types of surveillance
1. active: look for cases and report -ve 2. passive: routine data 3. enhanced: extra info (TB) 4. notifiable 5. sentinel: sample subset: eg GP for influenza 6. syndromic: symptoms GuMCAD STI surveillance system (report quarterly) global: GOARN (global outbreak alert and response network)
59
legal health protection laws
Public Health (Control of Disease) Act 1984 Health Protection Regulations 2010 - notifiable disease - closed consultation to update 1. local authority powers - responsible officer - without a JP - get notifiable disease reports -child away from school, get a school list, 2. part 2a powers (Health Protection (Part 2A orders) Regulations 2010) - JP required - restrict movement - restrict contact - shut venues not for treatment or vaccination Environment: - LA and EA have legal powers to control: waste, radioactive, water discharge LA: - Food (Food safety Act) - private water (public by WSI) - pests + nuisance
60
outbreak control
1. Outbreak control group 2. epi sequence: - case definition - confirm cases - confirm outbreak - collect cases - descriptive epi - epidemic curve - generate hypothesis - test hypothesis: analytical study 3. Control - source, pathway, receptor - immediate, medium, long term 4. communication - immediate, medium, long term
61
Diptheria
(swab, PCR) NOTIFIABLE c.diptheria or coynebacterium ulcerans Acute URTI - Membranous pharyngitis (pseudo membrane) - Fever - Enlarged anterior cerical lymph nodes and oedema: Bull necks - Toxin: paralysis and cardiac failure Incubation period: 2-5 days, infectious for 4 weeks Epidemiology: Low in UK: but high susceptibility (50% rising to 70% >70) UK cases: non toxigenic strain of c.dip: mild sore throat or TRAVEL c.ulcerans Resevoir: cattle Vaccine: - Toxin vaccine - Three doses as a child part of combination: DTaP/IPV/Hib - 2 3 4 months (+ 4 in 1 preschool booster + 3 in 1 teenage booster) Control: Cases: - Antitoxin in hospital - Antibiotics - Complete vaccine to UK schedule Contacts: antibiotic prophylaxis + vaccine Vaccine: booster, unvaccianted: schedule
62
Pertussis
Bordtella pertussis Notifiable (culture nasal, PCR, EIA) - Catarrhal stage: cough, cold, fever - Whoop cough - Apnea episodes Epidemiology: - Every 3/4 years, highest in autumn - 2012 outbreak: pregnant women vaccinated passive immunity: ROUTINE programme at 20 week scan (33% uptake in September 2024, ethnic disparities) - Outbreak in 2024 after COVID - Whole cell vaccine: prevent serious disease but not infection - HCW vaccine - acellular pertussis vaccine Routine to infants in 6 in 1 vaccine: 2, 3, 4 months DTaP/IPV/Hib/Hep B + 4 in 1 preschool booster Control: - Antibiotics - Vaccination Vulnerable contact : abx prophylaxis and vaccinate <10 years
63
Tetanus
(toxin in serum) Notifiable Toxin acute disease from clostridum tetani Incubation: 4-21 days Get: - Rigidity, spasms - Death Epi UK: routine immunisation 1961, low cases - PWID (people who inject drugs) main outbreaks Wounds, needles, abdo surgery Vaccine: cell free purified toxin - 2 3 4 months (+ 4 in 1 preschool booster + 3 in 1 teenage booster) Tetanus prone wounds: given Immunoglobin + vaccine
64
Polio
notifiable (viral culture, antibodies) Poliomyeleits - Gut then CNS Transmission: feaco-oral, or pharyngeal secretions UK Last natural case 1984 Most vaccine associated, some abroad Vaccine: OPV: good local gut immunity to wild polio, contact immunisation (can spread to others immunising them ), easy to administer Vs vaccine associated polio disease, cold chain, lots of doses --> therefore OPV outbreak, IPV routine 2 3 4 month schedule (+ 4 in 1 preschool booster + 3 in 1 teenage booster)
65
H infleunza B (Hib)
NOTIFIABLE a-f serotypes (these others less common) - Meningtitis (60%) - Epiglottitis Spread: airborne, close contacts Epidemiology: - Very low cases - Increased in 1999, catch up vaccine programme in 2003. booster at 12 months (part of routine) Conjugate vaccine Vaccine 2 3 4 months booster at 12 months Outbreaks: - Rifampicin prophylaxis (households of cases) Vaccine cluster cases
66
pneumococcal
notifiable Gram positive cocci - Penumonia - Meningtis - Sepsis Aerosol. Droplet, direct contact Epidemiology - Infants and elderly, winter - UK: 40,000 hospitalisation each year - Reduction in serotypes via vaccination Vaccine - 3 months and 1 year (PCV 13) - >65 years: 1 dose (PCV 23) Outbreak: - Vaccinate close contacts - Chemoprophylaxis
67
meningococcal meningitis and septicaemia
notifiable Gram negative diplococci 12 groups 6 groups cause serious disease: A, B, C, W135, X and Y Transmission: aerosol, droplet, direct contact Epidemiology - <5 years of age: 1 year peak (men B), and 15-19 years - Long term complications - Decreased since 1999: vaccine and then 2022 lockdown - Mass gatherings Vaccine: Men B (protein): 2 month, 4 months, 1 year MenC/Hib: 1 year ACWY vaccine (conjugate) : >14 years - 25 years Outbreak: - Chemoprophylaxis close contacts Vaccinate if strain preventable
68
TB
TB M.tuberculosis, bovis, africanum, microti Any part of body: 55% Pulmonary UK Respiratory route Natural course: - Eliminate - Latent - Active TB Epidemiology - Decline to 1980: reduction in general population - 1980 peak: high risk populations - Declining: peaks in 2010, one off increase in 2019 - Burden shifted to non-UK born, and at risk groups - Mortality decreased: BCG, treatment prevention: primary: BVG vaccine: at risk neonates (born high prev area, parents from high prev) or new immigrants 40 per 100,000 - Best for severe disease - Not for respiratory disease secondary: Port health Chest clinic Latent TB testing and treatment programme for migrants visa requirements tertiary - DOT - MDR-TB TB action plan 2021-26 - Recovery from covid - Prevent - Detect - Control - Workforce
69
mumps
Saliva, CSF, urine, serology notifiable Airborne and droplet Paramyxovirus - Bilateral parotid swelling - Asymptomatic - Meningism - Pancreatitis, oophritis, orchitis sensorineural deafness Epidemiology - Reduction since MMR vaccine - Peaks on 2003-2006, 2009, 2013, 2017-19 Outbreaks at university and colleges in the 'wakefield cohorts' - Missed out on MMR vaccine Vaccine: (live attenuated) MMR: 1 year, 3 y 4 months
70
measles
Morbillivirus of the paramyxovirus notifiable Airborne and droplet - Rash - Fever - Cough, coryza or conjunctivits Pregnant: miscarraige, LBW Complications: ottits media, pneumonia, encephalitis (post infection, delayed, SSPE subacute sclerosing panecphalitis ) Epidemiology: Decreased, since MMR but regular outbreaks Recently 2023-2024: West Midlands and London, small clusters in other regions (herd immunity 95% coverage needed) 2,601 cases since Jan 2024 MMR: 1 y -3y4m HNIG: - Within 72 hours - 6 days Contact to give: - < 6 months: all - 6-8 months if household (outside give MMR) - >9 months: MMR Pregnant woman if not vaccine
71
Rubella
Togavirus notifiable - Rash - Congenital rubella syndrome: highest risk in early trimester Epidemiology: - First vaccine programme was for pre-pubesent and women: to stop CRS - Then MMR - Risk in those from outside: not infected or immunised Vaccine: MMR
72
HPV
dsDNA virus >100 types, around 13 cause cancer - 16, 18 main cancer - 6 and 11 warts Epidemiology: - Complex due to high asymptomatic - Prior to vaccination rare <14 years then increased Cervical cancer: - Primary prevention: HPV vaccine - around 70% uptake - Decreasing since introduction (90% in cohort 1, to 70% recent cohort) similar trend in boys (81%-->67%) - Lowest in london Vaccine: - Gardasil 9 (6,11,16,18,31,33,45,52) - Given to boys and girls year 8 (12-13) + MSM - One dose mainly (>25 MSM 2 doses, HIV/IC 3 doses) - Cut cervical cancer by 87% for women in 20s who eligible for vaccine Secondary: - cervical cancer screening (as led to a 60% fall in C mortality 1974-2004) uptake falling 67-70% lower SEG and ethnic minority lowest uptake - Peak 30-34 then 80s - 3K cases a year Genital warts: - Was increasing prior to HPV vaccination now decreasing - Highest in men (14k) women (10k) NHS: eliminate cervical cancer by 2040 NHS App: ping and book for cervical screening
73
MRSA
Methicillin resistant staph - Cellulitis - Conjunctivities - Sepsis 30% of population ae colonised Epidemiology: - Plateaued since 2014 Prevention: personal hygiene Infection control Control: - Mandatory surveillance schemes (UKHSA) Decolonisation
74
C.diff
hospital associated Diahorrhea Epidemiology: Was plateauing but increase 2021 treatment: abx control: isolation
75
GI infections
Campylobacter Asymptoamtic to bloody diarrhoea Faeco-oral, raw food Epidemiology: - Around 50K cases Prevention: chlorination, pasterisation etc. Cholera Viberio cholea produce toxin Watery diarrhea, vomting, 50% case fatality f untreated Epi: endemic in developing, UK travel Control: Cases: ORT, abx, exlcusion Prevenion: travel advice Cryptospodidosis Self limiting if healthy Fatal if immunocompromised Epi: seasonal Faeco-oral Control: Exlclusion for 48 hrs, avoid swimming, Shigella Loose stools, watery can be bloody Faeco-oral route Epi: - increasing in MSM population - Travel - Children Control: - Abx E.Coli STEC: shiga toxin producing e.coli (0157 or non-0157) - lead to HUS - death - recent outbreak with 0145 HUS Notifiable Prevention: hand hygiene, cleaning, cooking Salmonella Diarrhoea Epi: endemic worldwide, outbreaks Animal to person, faeco-oral route Enteric fever (typhoid, and paratyphoid) notifiable Salmonella t and parat Oral or faeco-oral Epi: travellers, or contacts from India Vaccine: Vi polysaccharide, Ty21a: not part of schedule for travel vaccine Norovirus Faceo-oral route Exclude for 48 hrs Survives in envrioment, short immunity
76
hepatitis
Hep A - Asymptomatic -> fuliment hepatitis - Jaundice in adults Spread: - Faeco-oral - Person to person - Food and drink Epi: - Shifted to affect older adults - Downward trend in last 25 years - 2010 outbreak in London and south west - Outbreaks in MSM (faeco-oral route) - Frozen berries - Travel Vaccine Hep A only hep A/B: 2 doses 6 months apart Given to at risk groups (not part of routine in the UK) HNIG: - PEP for non-immune immunocompromised Hepatitis B Blood and bodily fluids (sex) MTCT -non specific prodrome illness Jaundice and fever HCC cirrhosis Hep D infection CHRONIC CARRIER Epidemiology: - 200,000 people with chronic hep B in the UK - Most migrants (95%), PWID, MSM, sex workers, detained - Acute hepatitis clusters MSM Vaccine: - Childhood imunisation 2 3 4 months in th Dtap/IPV/Hib/Heb B - Catch up vaccine for at risk groups MTCT - Univeral antenatal screening - HBIG for at risk mothers at b Chronic hep B - Long term management - Antiviral medications to supress Hepatitis C Blood - Carriers - Chronic hepatitis - Cirrhosis - Liver cancer Epi: - Main driver in the UK PWID - Reduction in Chronic hep c: due to increased treatment (as PWID infections stayed same) Control: Direct acting antiviral (DAA) especially at risk groups Prevention: needle
77
sexually transmitted infections
Chlamydia Commonest bacterail STI (194K diagnosis a year) Long term: PID, ectopic pregnancy, Highest <25 Nationally Chlamydia screening programme: women <25 sexually active: after sex with new partner or annually Why women: - Highest long term harm - No evidence that both gender reduced population prevalence - Testing women regularly reduce period of harm - Men: lower risk of harm and can clear infection without treatment UK increasing: 85K diagnosis Complications: PID, ectopic, septic arthiris Abx: Contact and partner tracing Condom HIV: Statistics: Prep need and on prep: - Need met for GBMSM: 85%, hetrosexual men 60%, hetrosexual woman 62% New diagnosis: - 6008 in England (51% increase) ○ MSML rose by 7% ○ Hetro: 36% increase ○ Over half diagnosed abroad Late diagnosis: - 896, (3% increase, black ethnicity highest) HIV care: - Age increasing - Tx coveraege covers 98% Gonorrhoea What is it: a bacterial infection Lead to PID , infertility Increased in 2023 Syphilis Bacterial infection Primary (chancre), secondary (rash), tertiary (disseminated) Increasing Highest in MSM 25-39 year olds Increasing in heterosexuals
78
chickenpox
varicella virus children: - often self limiting - secondary infections - days off school - pneumonitis, encephalitis, stroke JCVI: reccomend vaccine MMRV 2 doses - cost effective/ cost saving depending on vaccine price - used data from USA to model - less exogeneous boosting (middle aged adults get boost in immunity from circulating VZ, so less likely to get shingles)
79
Dahlgren and whitehead
80
Evans and stoddart
heath field model - functional status and wellbeing
81
diderichsen and hallqvist
social determinants framework - social stratification - diff exposure - diff vulnerability - diff outcomes
82
SEED (early education development) study
longitudinal study Attending high quality ECEC aged 2-4 --> better key stage 1 sores 40% most disadvantaged, >10 hrs free ECEC + <2 years --> better key stage 1 scores
83
Sure Start
IFS: Reduction in hospital admissions, Improved GCSE grades Long term outcomes initial early studies showed no effect
84
Family nurse partnership
Nurse for mothers <25 years of age Local commissioning from public health grant - Building blocks 1: RCT no short term outcome difference - Building blocks 2: follow up at 7 years. No difference on key stage 1, hospital usage
85
social marketing
1. identify target 2. research target 3. competitive analysis 4. set objective 5. develop message 6. sell message: product, price, place, promotion 7. evaluate